Novavax Market Cap

Novavax has a market cap or net worth of €965.22 million as of December 5, 2025. Its market cap has decreased by -20.25% in one year.

Market Cap

965.22M

Enterprise Value

525.31M

Revenue

907.40M

Ranking

n/a

PE Ratio

3.31

Stock Price

€5.82

Market Cap Chart

Since July 25, 1996, Novavax's market cap has increased from 27.26M to 965.22M, an increase of 3,440.73%. That is a compound annual growth rate of 12.91%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	965.22M	-22.41%
Dec 31, 2024	1.24B	141.15%
Dec 29, 2023	515.85M	-37.63%
Dec 30, 2022	827.03M	-91.31%
Dec 31, 2021	9.51B	185.25%
Dec 31, 2020	3.33B	3,909.57%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Merck KGaA	50.76B
Siemens Healthineers AG	47.23B
Bayer Aktiengesellschaft	33.66B
Fresenius SE & Co. KGaA	26.39B
Sartorius Aktiengesellschaft	15.28B
Fresenius Medical Care AG	11.73B
Carl Zeiss Meditec AG	3.76B
Fielmann Group AG	3.61B

Market Cap Rankings